JP2021514659A5 - - Google Patents

Info

Publication number
JP2021514659A5
JP2021514659A5 JP2020546347A JP2020546347A JP2021514659A5 JP 2021514659 A5 JP2021514659 A5 JP 2021514659A5 JP 2020546347 A JP2020546347 A JP 2020546347A JP 2020546347 A JP2020546347 A JP 2020546347A JP 2021514659 A5 JP2021514659 A5 JP 2021514659A5
Authority
JP
Japan
Prior art keywords
serotype
aav serotype
item
aav2
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020546347A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021514659A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/021048 external-priority patent/WO2019173538A1/en
Publication of JP2021514659A publication Critical patent/JP2021514659A/ja
Publication of JP2021514659A5 publication Critical patent/JP2021514659A5/ja
Priority to JP2023175237A priority Critical patent/JP2023171525A/ja
Pending legal-status Critical Current

Links

JP2020546347A 2018-03-06 2019-03-06 Aavキメラ Pending JP2021514659A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023175237A JP2023171525A (ja) 2018-03-06 2023-10-10 Aavキメラ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862639466P 2018-03-06 2018-03-06
US62/639,466 2018-03-06
PCT/US2019/021048 WO2019173538A1 (en) 2018-03-06 2019-03-06 Aav chimeras

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023175237A Division JP2023171525A (ja) 2018-03-06 2023-10-10 Aavキメラ

Publications (2)

Publication Number Publication Date
JP2021514659A JP2021514659A (ja) 2021-06-17
JP2021514659A5 true JP2021514659A5 (cg-RX-API-DMAC7.html) 2022-03-14

Family

ID=67846340

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020546347A Pending JP2021514659A (ja) 2018-03-06 2019-03-06 Aavキメラ
JP2023175237A Pending JP2023171525A (ja) 2018-03-06 2023-10-10 Aavキメラ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023175237A Pending JP2023171525A (ja) 2018-03-06 2023-10-10 Aavキメラ

Country Status (8)

Country Link
US (2) US11905524B2 (cg-RX-API-DMAC7.html)
EP (1) EP3762501A4 (cg-RX-API-DMAC7.html)
JP (2) JP2021514659A (cg-RX-API-DMAC7.html)
KR (1) KR20200130337A (cg-RX-API-DMAC7.html)
CN (1) CN112166195A (cg-RX-API-DMAC7.html)
AU (1) AU2019231711A1 (cg-RX-API-DMAC7.html)
CA (1) CA3092871A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019173538A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL314171A (en) 2015-09-28 2024-09-01 Univ Florida Methods and compositions for antibody-evading virus vectors
US11905524B2 (en) 2018-03-06 2024-02-20 University Of Florida Research Foundation, Incorporated AAV chimeras
CA3095179A1 (en) 2018-04-03 2019-10-10 Stridebio, Inc. Antibody-evading virus vectors
MX2020010465A (es) 2018-04-03 2021-01-08 Vectores de virus para direccionamiento a tejidos oftalmicos.
BR112020020266A2 (pt) 2018-04-03 2021-01-19 Stridebio, Inc. Vetores de vírus com evasão de anticorpos
CN113727992A (zh) 2019-03-21 2021-11-30 斯特里迪比奥公司 重组腺相关病毒载体
CN114787180A (zh) 2019-10-17 2022-07-22 斯特里迪比奥公司 用于治疗c型尼曼-匹克病的腺相关病毒载体
MX2022004353A (es) 2019-10-17 2022-07-19 Casete de transferencia de aav.
US12054738B2 (en) 2020-07-30 2024-08-06 Shape Therapeutics Inc. Stable cell lines for inducible production of rAAV virions
JP2023542614A (ja) 2020-08-19 2023-10-11 サレプタ セラピューティクス, インコーポレイテッド レット症候群の治療のためのアデノ随伴ウイルスベクター
WO2024143440A1 (ja) 2022-12-28 2024-07-04 富士フイルム株式会社 アデノ随伴ウイルスの製造方法、およびベクターのセット
AU2024223271A1 (en) * 2023-02-17 2025-09-18 Synplogen Co., Ltd. Itr-rep gene complex
CN116622908B (zh) * 2023-04-13 2024-02-06 武汉珈创生物技术股份有限公司 快速检测野生型腺相关病毒的引物探针、试剂盒及方法和应用
TW202548023A (zh) * 2024-03-14 2025-12-16 美商雅菲納治療公司 用於生產重組腺相關病毒的質體系統
US20260022401A1 (en) 2024-07-22 2026-01-22 Hoffmann-La Roche Inc. Novel AAV rep ORFs and Rep polypeptides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001517454A (ja) 1997-09-19 2001-10-09 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 組換えアデノ随伴ウイルスの産生に有用な方法および細胞株
EP1135468B1 (en) * 1998-11-10 2010-01-06 University Of North Carolina At Chapel Hill Virus vectors and methods of making and administering the same
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
AU2002367943A1 (en) 2001-12-18 2003-12-22 University Of North Carolina At Chapel Hill Improved reagents and methods for producing parvoviruses
CN1461805A (zh) * 2002-05-27 2003-12-17 本元正阳基因技术股份有限公司 一组重组单纯疱疹病毒的构建及其用途
CN101724608A (zh) * 2008-10-10 2010-06-09 中国疾病预防控制中心病毒病预防控制所 用于重组aav2/8病毒载体生产的重组i型单纯疱疹病毒及其用途
US9169494B2 (en) * 2010-01-12 2015-10-27 The University Of North Carolina At Chapel Hill Restrictive inverted terminal repeats for viral vectors
WO2017100674A1 (en) * 2015-12-11 2017-06-15 The Trustees Of The University Of Pennsylvania Scalable purification method for aav1
US11905524B2 (en) 2018-03-06 2024-02-20 University Of Florida Research Foundation, Incorporated AAV chimeras

Similar Documents

Publication Publication Date Title
IL317938A (en) Recombinant viral vectors with altered tropism and their uses for the targeted introduction of genetic material into human cells
JP6366581B2 (ja) 改変されたアデノ随伴ウイルスベクター組成物
JP2022190081A5 (cg-RX-API-DMAC7.html)
Bossis et al. Cloning of an avian adeno-associated virus (AAAV) and generation of recombinant AAAV particles
JP2020019772A5 (cg-RX-API-DMAC7.html)
EP2660325A3 (en) AAV vectors and corresponding nucleotide sequences and methods
JP2017509632A5 (cg-RX-API-DMAC7.html)
JP2021516046A5 (cg-RX-API-DMAC7.html)
JP2022529631A5 (cg-RX-API-DMAC7.html)
JP2020519284A5 (cg-RX-API-DMAC7.html)
JP2018108113A5 (cg-RX-API-DMAC7.html)
JP2020505936A5 (cg-RX-API-DMAC7.html)
RU2017125234A (ru) Конструкции нуклеиновой кислоты и векторы для генотерапии для применения для лечения болезни вильсона и других состояний
JP2018522529A5 (cg-RX-API-DMAC7.html)
JP2020522269A5 (cg-RX-API-DMAC7.html)
JP2022529424A5 (cg-RX-API-DMAC7.html)
RU2017116576A (ru) Композиции и способы лечения бокового амиотрофического склероза (als)
HRP20192141T1 (hr) Genska terapija za retinitis pigmentosa
JP2021523702A5 (cg-RX-API-DMAC7.html)
JP2018510648A5 (cg-RX-API-DMAC7.html)
JP2022520803A5 (cg-RX-API-DMAC7.html)
JP2021514659A (ja) Aavキメラ
JP2022551744A5 (cg-RX-API-DMAC7.html)
JP2023551873A5 (cg-RX-API-DMAC7.html)
JP2021521782A5 (cg-RX-API-DMAC7.html)